Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Insys Therapeutics goes public on second try; nets $34.2mm
05 Jun 2013
After filing to go public in March 2011, Insys Therapeutics Inc. (cancer, neurology, and gastrointestinal pharmaceuticals) has netted $34.2mm through the sale of 4.6mm common shares (including the overallotment) at $8. Last month the firm had proposed selling 4mm shares between $16-18 each, then weeks later lowered the price to $8-10. This was Insys's second IPO attempt; the first try was halted in 2007 due to market conditions.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?